These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31972760)

  • 1. Association Between Recent Cannabis Consumption and Withdrawal-Related Symptoms During Early Abstinence Among Females With Smoked Cocaine Use Disorder.
    Viola TW; Sanvicente-Vieira B; Kluwe-Schiavon B; Rothmann LM; Mélo-Pereira JVNE; Bicca C; Ottolia Niederauer JP; Schmitz J; Grassi-Oliveira R
    J Addict Med; 2020; 14(4):e37-e43. PubMed ID: 31972760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term cannabis abuse and early-onset cannabis use increase the severity of cocaine withdrawal during detoxification and rehospitalization rates due to cocaine dependence.
    Viola TW; Tractenberg SG; Wearick-Silva LE; Rosa CS; Pezzi JC; Grassi-Oliveira R
    Drug Alcohol Depend; 2014 Nov; 144():153-9. PubMed ID: 25262527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood neglect and increased withdrawal and depressive severity in crack cocaine users during early abstinence.
    Francke ID; Viola TW; Tractenberg SG; Grassi-Oliveira R
    Child Abuse Negl; 2013 Oct; 37(10):883-9. PubMed ID: 23988085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability and validity of the Cocaine Selective Severity Assessment.
    Kampman KM; Volpicelli JR; McGinnis DE; Alterman AI; Weinrieb RM; D'Angelo L; Epperson LE
    Addict Behav; 1998; 23(4):449-61. PubMed ID: 9698974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relation between gray matter volume and the use of alcohol, tobacco, cocaine and cannabis in male polysubstance users.
    Kaag AM; Schulte MHJ; Jansen JM; van Wingen G; Homberg J; van den Brink W; Wiers RW; Schmaal L; Goudriaan AE; Reneman L
    Drug Alcohol Depend; 2018 Jun; 187():186-194. PubMed ID: 29679913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine withdrawal symptoms identify "Type B" cocaine-dependent patients.
    Ahmadi J; Kampman K; Dackis C; Sparkman T; Pettinati H
    Am J Addict; 2008; 17(1):60-4. PubMed ID: 18214724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders.
    Crowley TJ; Macdonald MJ; Whitmore EA; Mikulich SK
    Drug Alcohol Depend; 1998 Mar; 50(1):27-37. PubMed ID: 9589270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances.
    Vandrey RG; Budney AJ; Hughes JR; Liguori A
    Drug Alcohol Depend; 2008 Jan; 92(1-3):48-54. PubMed ID: 17643868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.
    Kampman KM; Dackis C; Lynch KG; Pettinati H; Tirado C; Gariti P; Sparkman T; Atzram M; O'Brien CP
    Drug Alcohol Depend; 2006 Nov; 85(2):129-37. PubMed ID: 16697124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postdischarge cannabis use and its relationship to cocaine, alcohol, and heroin use: a prospective study.
    Aharonovich E; Liu X; Samet S; Nunes E; Waxman R; Hasin D
    Am J Psychiatry; 2005 Aug; 162(8):1507-14. PubMed ID: 16055773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid receptor gene modulates severity of depression in women with crack cocaine addiction.
    Rovaris DL; Aroche AP; da Silva BS; Kappel DB; Pezzi JC; Levandowski ML; Hess ARB; Schuch JB; de Almeida RMM; Grassi-Oliveira R; Bau CHD
    Eur Neuropsychopharmacol; 2016 Sep; 26(9):1438-1447. PubMed ID: 27397864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adolescent Exposure to the Synthetic Cannabinoid WIN 55212-2 Modifies Cocaine Withdrawal Symptoms in Adult Mice.
    Aguilar MA; Ledesma JC; Rodríguez-Arias M; Penalva C; Manzanedo C; Miñarro J; Arenas MC
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cocaine and alcohol: a risky association].
    Lacoste J; Pedrera-Melgire M; Charles-Nicolas A; Ballon N
    Presse Med; 2010 Mar; 39(3):291-302. PubMed ID: 19631491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-course of the DSM-5 cannabis withdrawal symptoms in poly-substance abusers.
    Hesse M; Thylstrup B
    BMC Psychiatry; 2013 Oct; 13():258. PubMed ID: 24118963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expectations about alcohol, cocaine, and benzodiazepine abstinence following inpatient heroin withdrawal management.
    Kenney SR; Anderson BJ; Bailey GL; Stein MD
    Am J Addict; 2019 Jan; 28(1):36-42. PubMed ID: 30548526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct effects of cocaine and cocaine + cannabis on neurocognitive functioning and abstinence: A six-month follow-up study.
    Oliveira HP; Gonçalves PD; Ometto M; Santos BD; Malbergier A; Amaral R; Nicastri S; Andrade AG; Cunha PJ
    Drug Alcohol Depend; 2019 Dec; 205():107642. PubMed ID: 31683245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocaine abstinence symptomatology and treatment attrition.
    Mulvaney FD; Alterman AI; Boardman CR; Kampman K
    J Subst Abuse Treat; 1999 Mar; 16(2):129-35. PubMed ID: 10023610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidity effects on cocaine dependence treatment and examination of reciprocal relationships between abstinence and depression.
    Milby JB; Conti K; Wallace D; Mennemeyer S; Mrug S; Schumacher JE
    J Consult Clin Psychol; 2015 Feb; 83(1):45-55. PubMed ID: 25329491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective assessment of cannabis withdrawal in adolescents with cannabis dependence: a pilot study.
    Milin R; Manion I; Dare G; Walker S
    J Am Acad Child Adolesc Psychiatry; 2008 Feb; 47(2):174-179. PubMed ID: 18176332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence for reduction of opioid-withdrawal symptoms by cannabis smoking during a methadone dose taper.
    Epstein DH; Preston KL
    Am J Addict; 2015 Jun; 24(4):323-8. PubMed ID: 25846329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.